MacroGenics (MGNX) PT Lowered to $5 at BMO Capital

August 7, 2024 9:23 AM

BMO Capital analyst Etzer Darout lowered the price target on MacroGenics (NASDAQ: MGNX) to $5.00 (from $8.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found